France· FR:63954950
SYNAREL 0,2 mg/dose, solution pour pulvérisation nasale
A nafarelin product containing acétate de nafaréline, registered in France by PFIZER HOLDING FRANCE, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Nafarelin is registered in 12 of 19 countries.
Countries holding a registration under ATC H01CA02 (nafarelin), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 6 of them publish a price we can compare per daily dose
Nafarelin · ATC H01CA02
12 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ACÉTATE DE NAFARÉLINE
- Manufacturer
- PFIZER HOLDING FRANCE
- Country
- France (FR)
- ATC code
- H01CA02
- ATC class
- Nafarelin
- Defined daily dose
- 0.4 mg, N
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009353521011 flacon(s) en verre de 8 ml avec embout nasal polypropylèneEUR 109.87
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nafarelin in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandSynarel 200 micrograms/dose Nasal Spray SolutionPfizer Healthcare Ireland Unlimited Company
- NorwaySynarelaPfizer AS
- FinlandSynarelaParanova Oy
- SwedenSynarela 200 mikrogram/dos Nässpray, lösningOrifarm AB
- CzechiaSYNARELPfizer, spol. s r.o., Praha
- IcelandSynarelaPfizer ApS
- NetherlandsSynarel, neusspray 200 microgram per dosisPfizer B.V.
- CanadaSYNARELPFIZER CANADA ULC
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Czechia · Synarel
- Germany · Synarela
- Denmark · Synarela
- Spain · Synarel
- Finland · Synarela
- United Kingdom (Northern Ireland) · Synarel
- Ireland · Synarel
- Iceland · Synarela
- Netherlands · Synarel
- Norway · Synarela
- Sweden · Synarela
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/75efb1ba-b427-4afd-822e-dd5ab56a2b8b GET /v1/drugs/75efb1ba-b427-4afd-822e-dd5ab56a2b8b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63954950",
"date_amm": "1990-07-27",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "ACÉTATE DE NAFARÉLINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution pour pulvérisation",
"voies_administration": "nasale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about nafarelin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.